So far, GSDMB has been reported in several diseases, most documented in asthma, cancers, and inflammatory bowel diseases (Feng et al., 2018; Kuc-Ciepluch et al., 2021; Zou et al., 2021). This evidence concerns the gene GSDMB and cancer.